Alongside the microfluidic experiments, RT-qPCR was performed for each biopsy to assess the presence of prostate cancer cells and several prostate cancer biomarkers: androgen receptors (ARs), prostate-specific androgen (KLK3) and alpha-methyl-acyl-CoA racemase (AMACR). This evidence concerns the gene AR and prostate carcinoma.